Schizophrenia Trial, Recruiting NCT07058389 Sponsor: Centre Hospitalier Universitaire de Saint Etienne Condition: Schizophrenia
Back to Schizophrenia

Schizophrenia Trial, Recruiting

NCT07058389
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People diagnosed with schizophrenia who are between 18 and 55 years old
  • People who have ongoing, persistent negative symptoms of schizophrenia, measured by a specific symptom scale scoring above 7 (confirm with trial site for what this means in practice)
  • People who are regularly seen and monitored by a psychiatry department
  • People who have no medical reasons preventing them from doing physical activity
  • People who are covered by or entitled to a social security system
  • People who have been fully informed about the study and have signed a consent form together with the investigator
  • Men or women are eligible

Who may not be able to join:

  • People the investigator considers unsuitable for the study for any reason
  • People who have ongoing joint problems, such as repeated sprains or knee and ligament issues, or who have heart conditions
  • People who have long-term or brain-related neurological conditions
  • People who are in custody or who are under legal guardianship or protection
  • People who drink more than 14 alcoholic drinks per week, or consume more than 400 mg of caffeine per day (roughly more than 4 standard cups of coffee)
  • Women who are pregnant
  • People who are unable to understand the purpose and conditions of the study or who are unable to give informed consent

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 26 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Medhi HOUSNI, Md, CHU de Saint-Etienne

Phone: (0)477127885

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Centre Hospitalier Universitaire de Saint Etienne
Registry
ClinicalTrials.gov
Start date
7 October 2025
Est. completion
1 June 2027

Where this trial is recruiting

🇫🇷 France

Primary endpoints

Self-evaluation of negative symptoms (SNS) questionnaire

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov